Highlights in Lung Cancer, 2013: MEK Inhibitors for KRAS Mutation-Positive NSCLC (audio)
- Author
- cancerGRACE - H. Jack West, MD
- Published
- Fri 29 Mar 2013
- Episode Link
- http://cancergrace.libsyn.com/highlights-in-lung-cancer-2013-mek-inhibitors-for-kras-mutation-positive-nsclc-audio
Dr. Natasha Leighl, Princess Margaret Hospital in Toronto, Canada, reviews exciting new data illustrating the potential benefits of the MEK inhibitor selumetinib in treating KRAS mutation-positive advanced non-small cell lung cancer.
